300 results
4-year outcomes after left atrial appendage closure versus Nonwarfarin oral anticoagulation for atrial fibrillation
24 Jan 2022
Left atrial appendage closure (LAAC) is a promising interventional treatment option for preventing cardioembolic events in non-valvular atrial fibrillation (AF) patients who can not tolerate long-term oral anticoagulation.
Reviewer
Cusp symmetry and coronary ostial eccentricity and its impact on coronary access following TAVR
26 Jan 2022
Recently, coronary access has been recognized as an important consideration in the lifetime management of patients with severe aortic stenosis...
Reviewer
30-day outcomes following transfemoral transseptal transcatheter mitral valve replacement: Intrepid TMVR early feasibility study results
21 Jan 2022
The study by Zahr et al. reports the results of an interim analysis assessing procedural and clinical outcomes at 30-day in 15 patients treated with the newly developed Medtronic Intrepid 35-F trans-femoral transcatheter mitral valve replacement (TMVR) system.
Reviewer
Defining percutaneous coronary intervention complexity and risk: an analysis of the UK BCIS Database 2006-2016
04 Jan 2022
A multiple logistic regression model was developed to identify variables associated with in-hospital MACCE and to construct a CHIP score. The cumulative effect of this score on patient outcomes was examined.
Reviewer
Iatrogenic atrial septal defects following transcatheter mitral valve repair and implications of interventional closures
21 Dec 2021
The authors investigated whether iatrogenic atrial septal defect closure post-transcatheter mitral valve edge-to-edge repair is superior to conservative therapy, and whether outcomes (death/heart failure hospitalization) differ between patients with and without an iASD post-TMVR.
Reviewer
Rivaroxaban monotherapy in patients with atrial fibrillation after coronary stenting: insights from the AFIRE trial
08 Nov 2021
In this prespecified subgroup analysis of the AFIRE trial, the authors report the outcomes of rivaroxaban monotherapy compared to rivaroxaban and an antiplatelet agent in patients with atrial fibrillation who underwent coronary stenting > 1 year prior to enrolment.
Reviewer
Fractional flow reserve to guide treatment of patients with multivessel coronary artery disease - the FUTURE trial
05 Nov 2021
The FUTURE Trial is a prospective randomised, multicentre, open label superiority trial comparing an FFR guided treatment strategy to traditional angiography guided treatment strategy on clinical outcomes in an all-comer population with multivessel coronary artery disease.
Reviewer
Impact of intravascular ultrasound on long-term clinical outcomes in patients with acute myocardial infarction
04 Nov 2021
There are limited data evaluating long-term outcomes of IVUS use in patients with acute myocardial infarction (AMI). The aim of this study was to examine the impact of IVUS-guided PCI on long-term clinical outcomes in patients with AMI.
Reviewer
Reviewer
Ticagrelor monotherapy in patients at high bleeding risk undergoing percutaneous coronary intervention: TWILIGHT-HBR
28 Oct 2021
To further investigate the treatment effects of ticagrelor monotherapy compared with ticagrelor plus aspirin in a contemporary HBR population, a pre-specified analysis of the TWILIGHT trial, TWILIGHT-HBR, was conducted by using the Academic Research Consortium (ARC) criteria for HBR.
Reviewer
Reviewer
ACTIVATION (percutAneous Coronary inTervention prIor to transcatheter aortic VAlve implantaTION): a randomized clinical trial
19 Oct 2021
In conducting the ACTIVATION trial, Redwood and colleagues seek to complement the existing literature with high-level evidence on whether percutaneous coronary intervention (PCI) prior to TAVR is non-inferior to conservative (no PCI) management.
Reviewer
Reviewer
